SB 225 requires Tennessee health insurers to reimburse chiropractic physicians at the same rate as medical doctors for identical services, amending Tennessee Code Annotated Titles 56 and 63. It prohibits insurers from using separate payment codes or methodologies for chiropractic services compared to physician services, ensuring equal reimbursement based on nationally recognized coding systems like the CPT book. This applies to private health insurance plans but excludes TennCare, CoverKids, and government-provided insurance. The bill aims to eliminate reimbursement disparities for chiropractors offering equivalent services to medical doctors. It was scheduled to take effect July 1, 2025, but failed in committee on March 25, 2025.
SB 579 would provide eligible Tennessee workers 12 weeks of job-protected leave for recovery after living organ donation surgery, with leave counted toward employment seniority. It prohibits insurers from denying coverage or charging more for life, disability, or long-term care insurance solely because someone is a living organ donor. The bill also requires the Tennessee Department of Health to create and post public educational materials about living organ donation by July 2025, covering benefits, risks, and insurance impacts. This bill directly affects living organ donors, employers, and insurance providers in Tennessee.
SB 1389 prohibits healthcare providers participating in Tennessee's TennCare or CoverKids programs from refusing to treat patients solely because they decline vaccines or immunizations. It requires the state to stop reimbursing providers who violate this rule and mandates the TennCare director to create implementing regulations. The law excludes oncology and organ transplant specialists from the prohibition. The bill takes effect July 1, 2025, with rules to be established under state administrative procedures.
HB 783 authorizes Tennessee local governments (counties, cities, or metropolitan areas) to regulate sober living homes - residences for adults recovering from substance abuse without formal treatment - to ensure they comply with federal fair housing and disability laws. Key provisions include requiring these homes to be at least 1,000 feet from schools/daycares, allowing local zoning rules, and mandating clinical referrals from licensed healthcare providers before residency. The law directly affects sober living home operators, residents, and local governments implementing these rules. It becomes effective immediately upon the governor’s signature (May 21, 2025), updating Tennessee housing codes to balance local oversight with federal civil rights protections.
SB 1414, effective May 5, 2025, strengthens Tennessee's alignment with the federal 340B drug discount program by prohibiting drug manufacturers from restricting access to 340B drugs or imposing unfair requirements on participating entities. The bill directly affects 340B entities (such as community health centers and hospitals) and their contracted pharmacies, banning actions like denying 340B drug access, demanding extra health data, or applying stricter audit rules than for non-340B providers. Key provisions require manufacturers to comply with federal 340B rules and prohibit interference with 340B entities' drug choices or contracts. Violations carry a $50,000 civil penalty per violation, enforceable by the state commissioner or attorney general. The law explicitly states it does not override applicable federal 340B regulations.
This resolution urges the U.S. Congress to require the Department of Veterans Affairs (VA) to include veterans who received certain COVID-19 treatments (administered under Emergency Use Authorization before full FDA approval) and anthrax vaccinations as qualifying exposures under the PACT Act. It directly affects veterans exposed to these treatments during service, potentially expanding their access to VA healthcare and benefits previously reserved for those with toxic exposures like burn pits. The resolution also calls for Congress to investigate the military's administration of these substances, including whether they were given without proper consent or approval. As a non-binding resolution, it does not change VA policy but advocates for legislative action to address veterans' health concerns.
SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
SB 1146 requires county medical examiners to test decedents involved in mass shootings (resulting in four or more deaths) for all drugs, including psychotropic medications used for mental health conditions. It mandates anonymized data sharing with the University of Tennessee Health Science Center and the Department of Health, prohibiting disclosure of identifying information. The health science center must study drug interactions and submit quarterly reports to legislative health committees. The law, effective July 1, 2025, applies to medical examiners, health agencies, and the University of Tennessee, while requiring compliance with privacy laws.
SB 955, now known as the "Medical Ethics Defense Act," protects Tennessee healthcare providers from being forced to participate in or pay for medical procedures that conflict with their conscience. It defines "conscience" as sincerely held ethical, moral, or religious beliefs and prohibits discriminatory actions - like termination or penalties - against providers who refuse specific procedures based on those beliefs. The law also safeguards providers who report violations of this act, preventing retaliation for whistleblowing. This applies to healthcare professionals, institutions, and payers but excludes procedures governed by federal law (such as emergency care under EMTALA).
SB 436 requires Tennessee's Medicaid program (TennCare) to consider using biosimilar drugs - cost-saving, FDA-approved versions of biologic medications - as part of its drug coverage strategy. It also allows health insurers to require patients to try a biosimilar before covering a branded drug, and directs the state's pharmacy advisory committee to factor biosimilar use into recommendations for the state drug formulary. The bill amends multiple Tennessee Code sections governing drug coverage, pharmacy practices, and formulary decisions. These changes aim to reduce prescription drug costs by expanding the use of biosimilars while maintaining FDA safety and efficacy standards. The bill directly affects TennCare patients, health insurers, and the state's drug formulary decision-making process.
